Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Angioli

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cancer|January 21, 2000
Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinomaG Cantuaria, A Magalhaes, R Angioli, et al.
Gynecologic Oncology|September 28, 2000
Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovaryG Cantuaria, A Magalhaes, M Penalver, et al.
Oncology|November 1, 1994
Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Oncology|January 1, 1994
Growth characteristics of nonmalignant cells in the ATP cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Gynecologic Oncology|April 1, 1994
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.
Gynecologic Oncology|November 1, 1992
Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroM Untch, B U Sevin, J P Perras, et al.
Gynecologic Oncology|July 1, 1993
The role of DNA index as a prognostic factor in early cervical carcinomaH N Nguyen, B U Sevin, H E Averette, et al.
Gynecologic Oncology|July 1, 1992
Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometryH N Nguyen, B U Sevin, H E Averette, et al.
Breast Cancer Research and Treatment|October 1, 1993
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignanciesR Angioli, I Palaia, M Calcagno, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer|January 21, 2000
Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinomaG Cantuaria, A Magalhaes, R Angioli, et al.
Gynecologic Oncology|September 28, 2000
Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovaryG Cantuaria, A Magalhaes, M Penalver, et al.
Oncology|November 1, 1994
Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Oncology|January 1, 1994
Growth characteristics of nonmalignant cells in the ATP cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Gynecologic Oncology|April 1, 1994
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.
Gynecologic Oncology|November 1, 1992
Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroM Untch, B U Sevin, J P Perras, et al.
Gynecologic Oncology|July 1, 1993
The role of DNA index as a prognostic factor in early cervical carcinomaH N Nguyen, B U Sevin, H E Averette, et al.
Gynecologic Oncology|July 1, 1992
Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometryH N Nguyen, B U Sevin, H E Averette, et al.
Breast Cancer Research and Treatment|October 1, 1993
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignanciesR Angioli, I Palaia, M Calcagno, et al.
Pageof 8